Dr. Parvez Mantry, MD
Claim this profileThe Liver Institute at Methodist Dallas Medical Center
About Parvez Mantry, MD
Education:
- Earned an MD from the University of Bombay, India.
- Completed Residency at Metropolitan Hospital Center, New York Medical College.
- Undertook a Fellowship in Gastroenterology at the University of Rochester School of Medicine, New York.
Experience:
- Board certified in Internal Medicine, Gastroenterology, and Transplant Hepatology.
- Serves as Medical Director for Liver Institute Research and the Hepatobiliary Tumor Program at The Liver Institute at Methodist Dallas Medical Center.
- Led a pioneering team in performing fully robotic Whipple and liver resection procedures in North Texas.
Affiliated Hospitals
The Liver Institute At Methodist Dallas Medical Center
Methodist Transplant Physicians
Clinical Trials Parvez Mantry, MD is currently running
Enhanced Liver Function Test
for Fatty Liver
In this initial investigator-initiated retrospective study, aim to analyze the enhanced liver fibrosis (ELF) scores in this high-risk population for NAFLD/nonalcoholic steatohepatitis(NASH)-related fibrosis. Study define 'high-risk' to include metabolic syndrome, which can be further defined by an atherosclerotic cardiovascular disease (ASCVD) score \>7.5, any diagnosis of hyperlipidemia, history of coronary artery disease, history of heart failure, hypertension and/or type 2 diabetes. Study would also like to compare the performance of this score with historical methods of fibrosis assessment, where applicable, including vibration-controlled transient elastography, magnetic resonance elastography, blood markers and liver biopsy. Study will assess the impact of ELF scores on predicting liver events in the time, have used it and determine if diet, lifestyle changes and/or pharmacotherapy will improve serial ELF scores. Will also seek to understand how ELF scores are distributed in our community.
Recruiting
1 award
N/A
2 criteria
INT-787
for Alcoholic Hepatitis
This trial tests a new drug called INT-787 for people with severe liver damage from heavy drinking. It aims to see if the drug is safe and effective, and how the body processes it. The goal is to find out if INT-787 can help improve liver health in these patients. Previous studies have shown that similar treatments can protect against liver injury.
Recruiting
0 awards
Phase 2
More about Parvez Mantry, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Parvez Mantry, MD has experience with
- Placebo
- INT-787
- Nivolumab
- Ipilimumab
- Lenvatinib
- Sorafenib
Breakdown of trials Parvez Mantry, MD has run
Liver Cancer
Primary Sclerosing Cholangitis
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Parvez Mantry, MD specialize in?
Parvez Mantry, MD focuses on Liver Cancer and Primary Sclerosing Cholangitis. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Parvez Mantry, MD currently recruiting for clinical trials?
Yes, Parvez Mantry, MD is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Parvez Mantry, MD has studied deeply?
Yes, Parvez Mantry, MD has studied treatments such as Placebo, INT-787, Nivolumab.
What is the best way to schedule an appointment with Parvez Mantry, MD?
Apply for one of the trials that Parvez Mantry, MD is conducting.
What is the office address of Parvez Mantry, MD?
The office of Parvez Mantry, MD is located at: The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas 75203 United States. This is the address for their practice at the The Liver Institute at Methodist Dallas Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.